Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia

PURPOSE: To evaluate if off-label Age-Related Eye Disease Study 2 (AREDS2) supplementation prevents visual and anatomical deterioration in non-proliferative Idiopathic Macular Telangiectasia Type 2 (IMT2). PATIENTS AND METHODS: This is a single-center retrospective, comparative study of 82 IMT2 eyes...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Tyler A, Manry, Matthew W, Lindsell, Lucas B, Osher, James M, Miller, Daniel M, Foster, Robert E, Riemann, Christopher D, Petersen, Michael R, Sisk, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979356/
https://www.ncbi.nlm.nih.gov/pubmed/33758496
http://dx.doi.org/10.2147/OPTH.S294789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979356/
https://www.ncbi.nlm.nih.gov/pubmed/33758496
http://dx.doi.org/10.2147/OPTH.S294789

Ejemplares similares